Learn how novel approaches to clinical trial design, including integrated models and adaptive methods, are addressing the high costs and inefficiency of traditional drug development, particularly in Phase II and III trials, to reduce attrition rates and increase productivity.

 PTSD is highly prevalent among US veterans. This study found that among older veterans, a PTSD diagnosis conferred a significantly increased risk of developing dementia, with rates higher throughout the follow-up period. This underscores the importance of screening and treatment for those with PTSD.

Explore the Hepatitis B global clinical trial landscape in 2025 with insights into novel therapies, ongoing research for a functional cure, emerging biomarkers, and investment trends from a new report by Novotech

Acquire knowledge concerning Alzheimer's disease diagnosis, prevailing symptomatic treatments, and ongoing research initiatives dedicated to early intervention strategies and therapeutic approaches targeting amyloid and tau proteins.

Explore the critical topic of minority engagement in US clinical research on the Glassbury Cares Podcast. We discuss the persistent challenges of lower participation rates among racial and ethnic minorities in clinical trials, including HIV research. Understand how distrust of the medical community and research, significantly influenced by historical events like the Tuskegee study, acts as a barrier. Learn about other impediments, such as accessibility issues, time commitments, language barriers, stigma, and limited knowledge. Discover facilitators that encourage participation, including altruism, perceived personal and community benefits, trust, culturally relevant services, and monetary compensation. We examine ethical considerations, the importance of justice, and strategies like community-based participatory research to build trust and address structural barriers